Cargando…
Structural Variations in the Central Heterocyclic Scaffold of Tripartite 2,6-Difluorobenzamides: Influence on Their Antibacterial Activity against MDR Staphylococcus aureus
Five series of heterocyclic tripartite 2,6-difluorobenzamides, namely 1,2,3-triazoles, 1,2,4- and 1,3,4-oxadiazoles, analogs of reported model anti-staphylococcal compounds, were prepared. The purpose was to investigate the influence of the nature of the heterocyclic central scaffold on the biologic...
Autores principales: | Barbier, Thibaut, Badiou, Cédric, Davy, Floriane, Queneau, Yves, Dumitrescu, Oana, Lina, Gérard, Soulère, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573484/ https://www.ncbi.nlm.nih.gov/pubmed/36235156 http://dx.doi.org/10.3390/molecules27196619 |
Ejemplares similares
-
Importance of the 2,6-Difluorobenzamide Motif for FtsZ Allosteric Inhibition: Insights from Conformational Analysis, Molecular Docking and Structural Modifications
por: Barbier, Thibaut, et al.
Publicado: (2023) -
Synthesis and Biological Evaluation of Benzo[b]thiophene Acylhydrazones as Antimicrobial Agents against Multidrug-Resistant Staphylococcus aureus
por: Barbier, Thibaut, et al.
Publicado: (2022) -
Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 M(Pro) by targeting the cysteine 145
por: Soulère, Laurent, et al.
Publicado: (2021) -
In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Main Protease among a PubChem Database of Avian Infectious Bronchitis Virus 3CLPro Inhibitors
por: Soulère, Laurent, et al.
Publicado: (2023) -
N-(4-Cyanophenyl)-2,6-difluorobenzamide
por: Fun, Hoong-Kun, et al.
Publicado: (2010)